1-3 of 3
Jian-Kang Jiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Small Molecule FLT3 Inhibitors for the Treatment of FLT3-ITD AML

Katelyn Melgar, MacKenzie Walker, Jian-kang Jiang, PhD, Kelli Wilson, PhD, James C. Mulloy, PhD, Craig J Thomas, PhD, Daniel T Starczynowski, PhD
Journal: Blood
Blood (2015) 126 (23): 3690.
https://doi.org/10.1182/blood.V126.23.3690.3690
Published: 2015
Journal Articles

Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK–mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma

Scott R. P. McDonnell, Steven R. Hwang, Delphine Rolland, Carlos Murga-Zamalloa, Venkatesha Basrur, Kevin P. Conlon, Damian Fermin, Thomas Wolfe, Alexander Raskind, Chunhai Ruan, Jian-Kang Jiang, Craig J. Thomas, Cory M. Hogaboam, Charles F. Burant, Kojo S. J. Elenitoba-Johnson, Megan S. Lim
Journal: Blood
Blood (2013) 122 (6): 958–968.
https://doi.org/10.1182/blood-2013-01-482026
Published: 2013
Includes: Supplemental data
Journal Articles

CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP

Wei Ju, Meili Zhang, Jian-kang Jiang, Craig J. Thomas, Unsong Oh, Bonita R. Bryant, Jing Chen, Noriko Sato, Yutaka Tagaya, John C. Morris, John E. Janik, Steven Jacobson, Thomas A. Waldmann
Journal: Blood
Blood (2011) 117 (6): 1938–1946.
https://doi.org/10.1182/blood-2010-09-305425
Published: 2011
Includes: Supplemental data